CVS Health Corporation
CVS
$65.82
$0.9751.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| Weiss Ratings | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C+ | |||
| Rating Factors | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.60 | |||
| Price History | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.57% | |||
| 30-Day Total Return | 15.75% | |||
| 60-Day Total Return | 34.52% | |||
| 90-Day Total Return | 18.27% | |||
| Year to Date Total Return | 50.82% | |||
| 1-Year Total Return | -8.28% | |||
| 2-Year Total Return | -6.61% | |||
| 3-Year Total Return | -30.18% | |||
| 5-Year Total Return | 29.25% | |||
| 52-Week High % Change | -19.70% | |||
| 52-Week Low % Change | 48.85% | |||
| Price | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $80.75 | |||
| 52-Week Low Price | $43.56 | |||
| 52-Week Low Price (Date) | Dec 23, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 81.75B | |||
| Enterprise Value | 153.85B | |||
| Price/Earnings (TTM) | 17.70 | |||
| Earnings Per Share (TTM) | 3.66 | |||
| Earnings Per Share Growth | -43.35% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.22 | |||
| Price/Book (Q) | 1.08 | |||
| Enterprise Value/Revenue (TTM) | 0.42 | |||
| Price | $65.86 | |||
| Enterprise Value/EBITDA (TTM) | 12.19 | |||
| Enterprise Value/EBIT | 19.19 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.26B | |||
| Dividend Yield | 4.10% | |||
| Div. Per Share (Most Recent) | $0.67 | |||
| Dividend Per Share (TTM) | $2.66 | |||
| Payout Ratio (TTM) | 73.10% | |||
| Dividend Per Share (Most Recent) | $0.67 | |||
| Company Info | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 401 765 1500 | |||
| Address | One CVS Drive Woonsocket, RI 02895 | |||
| Website | www.cvshealth.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 2.16% | |||
| Profit Margin | 1.24% | |||
| Management Effectiveness | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.99% | |||
| Return on Equity | 6.02% | |||
| Income Statement | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 370.66B | |||
| Total Revenue (TTM) | 370.66B | |||
| Revenue Per Share | $293.94 | |||
| Gross Profit (TTM) | 49.25B | |||
| EBITDA (TTM) | 12.62B | |||
| EBIT (TTM) | 8.02B | |||
| Net Income (TTM) | 4.61B | |||
| Net Income Avl. to Common (TTM) | 4.61B | |||
| Total Revenue Growth (Q YOY) | 3.65% | |||
| Earnings Growth (Q YOY) | -20.71% | |||
| EPS Diluted (TTM) | 3.66 | |||
| EPS Diluted Growth (Q YOY) | -17.80% | |||
| Balance Sheet | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 10.99B | |||
| Cash Per Share (Q) | $8.72 | |||
| Total Current Assets (Q) | 68.65B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 75.73B | |||
| Current Ratio (Q) | 0.811 | |||
| Book Value Per Share (Q) | $59.97 | |||
| Total Assets (Q) | 253.22B | |||
| Total Current Liabilities (Q) | 84.61B | |||
| Total Debt (Q) | 82.92B | |||
| Total Liabilities (Q) | 177.49B | |||
| Total Common Equity (Q) | 75.56B | |||
| Cash Flow | CVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.61B | |||
| Cash from Financing (TTM) | -1.14B | |||
| Net Change in Cash (TTM) | 359.00M | |||
| Levered Free Cash Flow (TTM) | 6.64B | |||
| Cash from Operations (TTM) | 9.11B | |||
